Columbia Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.33M | Sell |
61,560
-664
| -1% | -$63.6K | 1.02% | 29 |
|
|
2025
Q4 | $5.98M | Buy |
62,224
+688
| +1% | +$66.8K | 1.06% | 24 |
|
|
2025
Q3 | $5.86M | Buy |
61,536
+1,315
| +2% | +$121K | 1.1% | 24 |
|
|
2025
Q2 | $5.25M | Buy |
60,221
+4,130
| +7% | +$350K | 1.03% | 27 |
|
|
2025
Q1 | $5.04M | Buy |
56,091
+2,455
| +5% | +$220K | 0.99% | 31 |
|
|
2024
Q4 | $4.28M | Sell |
53,636
-1,410
| -3% | -$122K | 0.78% | 37 |
|
|
2024
Q3 | $4.96M | Buy |
55,046
+5,254
| +11% | +$442K | 0.86% | 35 |
|
|
2024
Q2 | $3.92M | Buy |
49,792
+16,852
| +51% | +$1.38M | 0.73% | 42 |
|
|
2024
Q1 | $2.71M | Hold |
32,940
| – | – | 0.55% | 48 |
|
|
2023
Q4 | $2.71M | Buy |
32,940
+3,103
| +10% | +$236K | 0.55% | 48 |
|
|
2023
Q3 | $2.34M | Buy |
29,837
+35
| +0.1% | +$2.93K | 0.52% | 48 |
|
|
2023
Q2 | $2.63M | Buy |
29,802
+6,645
| +29% | +$572K | 0.56% | 47 |
|
|
2023
Q1 | $1.87M | Buy |
23,157
+9,332
| +68% | +$761K | 0.42% | 58 |
|
|
2022
Q4 | $1.07M | Buy |
13,825
+276
| +2% | +$22.4K | 0.26% | 70 |
|
|
2022
Q3 | $1.09M | Sell |
13,549
-2,202
| -14% | -$198K | 0.29% | 66 |
|
|
2022
Q2 | $1.41M | Buy |
+15,751
| New | +$1.6M | 0.36% | 62 |
|
|
2021
Q4 | $1.89M | Sell |
18,282
-3,926
| -18% | -$455K | 0.38% | 58 |
|
|
2021
Q3 | $2.78M | Sell |
22,208
-350
| -2% | -$45.3K | 0.61% | 47 |
|
|
2021
Q2 | $2.8M | Sell |
22,558
-14,028
| -38% | -$1.76M | 0.62% | 47 |
|
|
2021
Q1 | $4.32M | Buy |
36,586
+1,160
| +3% | +$136K | 0.78% | 37 |
|
|
2020
Q4 | $4.15M | Buy |
35,426
+2,775
| +8% | +$305K | 0.84% | 37 |
|
|
2020
Q3 | $3.39M | Buy |
32,651
+730
| +2% | +$73.3K | 0.78% | 38 |
|
|
2020
Q2 | $2.93M | Buy |
31,921
+9,095
| +40% | +$872K | 0.7% | 43 |
|
|
2020
Q1 | $2.06M | Buy |
22,826
+537
| +2% | +$57.1K | 0.51% | 45 |
|
|
2019
Q4 | $25.3K | Buy |
22,289
+3,450
| +18% | +$379K | 0.61% | 46 |
|
|
2019
Q3 | $2.05M | Hold |
18,839
| – | – | 0.53% | 49 |
|
|
2019
Q2 | $1.83M | Hold |
18,839
| – | – | 0.48% | 49 |
|
|
2019
Q1 | $1.72M | Buy |
18,839
+119
| +0.6% | +$10.7K | 0.46% | 50 |
|
|
2018
Q4 | $1.7M | Hold |
18,720
| – | – | 0.52% | 48 |
|
|
2018
Q3 | $1.84M | Buy |
18,720
+300
| +2% | +$27.7K | 0.48% | 52 |
|
|
2018
Q2 | $1.58M | Sell |
18,420
-300
| -2% | -$25.1K | 0.46% | 57 |
|
|
2018
Q1 | $1.5M | Hold |
18,720
| – | – | 0.44% | 58 |
|
|
2017
Q4 | $1.51M | Sell |
18,720
-500
| -3% | -$40K | 0.43% | 58 |
|
|
2017
Q3 | $1.5M | Hold |
19,220
| – | – | 0.46% | 55 |
|
|
2017
Q2 | $1.71M | Buy |
19,220
+528
| +3% | +$44.5K | 0.55% | 54 |
|
|
2017
Q1 | $1.5M | Hold |
18,692
| – | – | 0.5% | 55 |
|
|
2016
Q4 | $1.33M | Hold |
18,692
| – | – | 0.45% | 55 |
|
|
2016
Q3 | $1.61M | Buy |
18,692
+96
| +0.5% | +$8.37K | 0.57% | 53 |
|
|
2016
Q2 | $1.61M | Buy |
18,596
+78
| +0.4% | +$6.31K | 0.57% | 51 |
|
|
2016
Q1 | $1.39M | Buy |
18,518
+250
| +1% | +$18.8K | 0.51% | 55 |
|
|
2015
Q4 | $1.41M | Hold |
18,268
| – | – | 0.56% | 48 |
|
|
2015
Q3 | $1.22M | Sell |
18,268
-2,570
| -12% | -$189K | 0.5% | 56 |
|
|
2015
Q2 | $1.54M | Sell |
20,838
-1,000
| -5% | -$76.4K | 0.59% | 52 |
|
|
2015
Q1 | $1.7M | Hold |
21,838
| – | – | 0.64% | 45 |
|
|
2014
Q4 | $1.58M | Hold |
21,838
| – | – | 0.61% | 50 |
|
|
2014
Q3 | $1.35M | Sell |
21,838
-200
| -0.9% | -$12.7K | 0.55% | 52 |
|
|
2014
Q2 | $1.41M | Buy |
22,038
+200
| +0.9% | +$12.2K | 0.57% | 55 |
|
|
2014
Q1 | $1.34M | Hold |
21,838
| – | – | 0.58% | 56 |
|
|
2013
Q4 | $1.25M | Buy |
+21,838
| New | +$1.24M | 0.55% | 60 |
|
Other funds holding MDT
VCM
VPM
Columbia Asset Management's MDT Position: Q1 2026 in Review
Columbia Asset Management reduced its Medtronic (MDT) stake by 1.1% in Q1 2026, selling an estimated $63.6K and leaving 61,560 shares worth $5.33M. The position accounts for 1.02% of the portfolio, ranked #29.
Columbia Asset Management first reported a position in MDT in Q4 2013 and has held it in 49 quarters since. The position peaked at $5.98M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Columbia Asset Management held 61,560 shares of Medtronic worth $5.33M as of Q1 2026.
- Columbia Asset Management sold 664 Medtronic shares in Q1 2026, an estimated $63.6K.
- Medtronic made up 1.02% of Columbia Asset Management's portfolio in Q1 2026, its #29 holding.
- Columbia Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 49 quarters since.
- Columbia Asset Management's Medtronic position peaked at $5.98M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Columbia Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.